1 Market Overview

1.1 Neuromodulation Devices and Implantable Infusion Pumps Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 Spinal Cord Stimulation

1.2.3 Deep Brain Stimulation

1.2.4 Sacral Nerve Stimulation

1.2.5 Vagal Nerve Stimulation

1.2.6 Gastric Stimulation

1.2.7 Transcranial Magnetic Stimulation

1.2.8 Transcutaneous Electrical Stimulation

1.2.9 Other

1.3 Market Analysis by Application

1.3.1 Overview: Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Parkinson's Disease

1.3.3 Epilepsy

1.3.4 Pain

1.3.5 Other

1.4 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size & Forecast

1.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales in Volume (2017-2028)

1.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price (2017-2028)

1.5 Global Neuromodulation Devices and Implantable Infusion Pumps Production Capacity Analysis

1.5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Total Production Capacity (2017-2028)

1.5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Neuromodulation Devices and Implantable Infusion Pumps Market Drivers

1.6.2 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints

1.6.3 Neuromodulation Devices and Implantable Infusion Pumps Trends Analysis

2 Manufacturers Profiles

2.1 Medtronic

2.1.1 Medtronic Details

2.1.2 Medtronic Major Business

2.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product and Services

2.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 Boston Scientific Corporation

2.2.1 Boston Scientific Corporation Details

2.2.2 Boston Scientific Corporation Major Business

2.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product and Services

2.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 St. Jude Medical

2.3.1 St. Jude Medical Details

2.3.2 St. Jude Medical Major Business

2.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services

2.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Synapse Biomedical

2.4.1 Synapse Biomedical Details

2.4.2 Synapse Biomedical Major Business

2.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services

2.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 Nevro Corporation

2.5.1 Nevro Corporation Details

2.5.2 Nevro Corporation Major Business

2.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product and Services

2.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6 Neuropace

2.6.1 Neuropace Details

2.6.2 Neuropace Major Business

2.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product and Services

2.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7 Cyberonics

2.7.1 Cyberonics Details

2.7.2 Cyberonics Major Business

2.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product and Services

2.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8 Autonomic Technologies

2.8.1 Autonomic Technologies Details

2.8.2 Autonomic Technologies Major Business

2.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product and Services

2.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9 Avery Biomedical

2.9.1 Avery Biomedical Details

2.9.2 Avery Biomedical Major Business

2.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services

2.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10 Greatbatch Medical

2.10.1 Greatbatch Medical Details

2.10.2 Greatbatch Medical Major Business

2.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services

2.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Neuromodulation Devices and Implantable Infusion Pumps Breakdown Data by Manufacturer

3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Neuromodulation Devices and Implantable Infusion Pumps

3.4 Market Concentration Rate

3.4.1 Top 3 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer Market Share in 2021

3.4.2 Top 6 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer Market Share in 2021

3.5 Global Neuromodulation Devices and Implantable Infusion Pumps Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Neuromodulation Devices and Implantable Infusion Pumps Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region

4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales in Volume by Region (2017-2028)

4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2017-2028)

4.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue (2017-2028)

4.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue (2017-2028)

4.4 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue (2017-2028)

4.5 South America Neuromodulation Devices and Implantable Infusion Pumps Revenue (2017-2028)

4.6 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales in Volume by Type (2017-2028)

5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2017-2028)

5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales in Volume by Application (2017-2028)

6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2017-2028)

6.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2017-2028)

7.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2017-2028)

7.3 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country

7.3.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales in Volume by Country (2017-2028)

7.3.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2017-2028)

8.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2017-2028)

8.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country

8.3.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales in Volume by Country (2017-2028)

8.3.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2017-2028)

9.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2017-2028)

9.3 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region

9.3.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2017-2028)

10.2 South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2017-2028)

10.3 South America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country

10.3.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales in Volume by Country (2017-2028)

10.3.2 South America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2017-2028)

11.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2017-2028)

11.3 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country

11.3.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Neuromodulation Devices and Implantable Infusion Pumps and Key Manufacturers

12.2 Manufacturing Costs Percentage of Neuromodulation Devices and Implantable Infusion Pumps

12.3 Neuromodulation Devices and Implantable Infusion Pumps Production Process

12.4 Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Neuromodulation Devices and Implantable Infusion Pumps Typical Distributors

13.3 Neuromodulation Devices and Implantable Infusion Pumps Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Medtronic Basic Information, Manufacturing Base and Competitors

Table 4. Medtronic Major Business

Table 5. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product and Services

Table 6. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors

Table 8. Boston Scientific Corporation Major Business

Table 9. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product and Services

Table 10. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. St. Jude Medical Basic Information, Manufacturing Base and Competitors

Table 12. St. Jude Medical Major Business

Table 13. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services

Table 14. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Synapse Biomedical Basic Information, Manufacturing Base and Competitors

Table 16. Synapse Biomedical Major Business

Table 17. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services

Table 18. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. Nevro Corporation Basic Information, Manufacturing Base and Competitors

Table 20. Nevro Corporation Major Business

Table 21. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product and Services

Table 22. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. Neuropace Basic Information, Manufacturing Base and Competitors

Table 24. Neuropace Major Business

Table 25. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product and Services

Table 26. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 27. Cyberonics Basic Information, Manufacturing Base and Competitors

Table 28. Cyberonics Major Business

Table 29. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product and Services

Table 30. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 31. Autonomic Technologies Basic Information, Manufacturing Base and Competitors

Table 32. Autonomic Technologies Major Business

Table 33. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product and Services

Table 34. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 35. Avery Biomedical Basic Information, Manufacturing Base and Competitors

Table 36. Avery Biomedical Major Business

Table 37. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services

Table 38. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 39. Greatbatch Medical Basic Information, Manufacturing Base and Competitors

Table 40. Greatbatch Medical Major Business

Table 41. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services

Table 42. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 43. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Unit)

Table 44. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 45. Market Position of Manufacturers in Neuromodulation Devices and Implantable Infusion Pumps, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 46. Global Neuromodulation Devices and Implantable Infusion Pumps Production Capacity by Company, (Unit): 2020 VS 2021

Table 47. Head Office and Neuromodulation Devices and Implantable Infusion Pumps Production Site of Key Manufacturer

Table 48. Neuromodulation Devices and Implantable Infusion Pumps New Entrant and Capacity Expansion Plans

Table 49. Neuromodulation Devices and Implantable Infusion Pumps Mergers & Acquisitions in the Past Five Years

Table 50. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2017-2022) & (Unit)

Table 51. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2023-2028) & (Unit)

Table 52. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2017-2022) & (USD Million)

Table 53. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2023-2028) & (USD Million)

Table 54. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2017-2022) & (Unit)

Table 55. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2023-2028) & (Unit)

Table 56. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2017-2022) & (USD Million)

Table 57. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2023-2028) & (USD Million)

Table 58. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2017-2022) & (USD/Unit)

Table 59. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2023-2028) & (USD/Unit)

Table 60. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2017-2022) & (Unit)

Table 61. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2023-2028) & (Unit)

Table 62. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2017-2022) & (USD Million)

Table 63. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2023-2028) & (USD Million)

Table 64. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2017-2022) & (USD/Unit)

Table 65. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2023-2028) & (USD/Unit)

Table 66. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2017-2022) & (Unit)

Table 67. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2023-2028) & (Unit)

Table 68. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2017-2022) & (USD Million)

Table 69. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2023-2028) & (USD Million)

Table 70. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2017-2022) & (Unit)

Table 71. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2023-2028) & (Unit)

Table 72. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2017-2022) & (Unit)

Table 73. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2023-2028) & (Unit)

Table 74. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2017-2022) & (Unit)

Table 75. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2023-2028) & (Unit)

Table 76. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2017-2022) & (USD Million)

Table 77. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2023-2028) & (USD Million)

Table 78. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2017-2022) & (Unit)

Table 79. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2023-2028) & (Unit)

Table 80. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2017-2022) & (Unit)

Table 81. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2023-2028) & (Unit)

Table 82. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2017-2022) & (Unit)

Table 83. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2023-2028) & (Unit)

Table 84. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2017-2022) & (USD Million)

Table 85. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2023-2028) & (USD Million)

Table 86. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2017-2022) & (Unit)

Table 87. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2023-2028) & (Unit)

Table 88. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2017-2022) & (Unit)

Table 89. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2023-2028) & (Unit)

Table 90. South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2017-2022) & (Unit)

Table 91. South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2023-2028) & (Unit)

Table 92. South America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2017-2022) & (USD Million)

Table 93. South America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2023-2028) & (USD Million)

Table 94. South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2017-2022) & (Unit)

Table 95. South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2023-2028) & (Unit)

Table 96. South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2017-2022) & (Unit)

Table 97. South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2023-2028) & (Unit)

Table 98. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2017-2022) & (Unit)

Table 99. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2023-2028) & (Unit)

Table 100. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2017-2022) & (USD Million)

Table 101. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2023-2028) & (USD Million)

Table 102. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2017-2022) & (Unit)

Table 103. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2023-2028) & (Unit)

Table 104. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2017-2022) & (Unit)

Table 105. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2023-2028) & (Unit)

Table 106. Neuromodulation Devices and Implantable Infusion Pumps Raw Material

Table 107. Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps Raw Materials

Table 108. Direct Channel Pros & Cons

Table 109. Indirect Channel Pros & Cons

Table 110. Neuromodulation Devices and Implantable Infusion Pumps Typical Distributors

Table 111. Neuromodulation Devices and Implantable Infusion Pumps Typical Customers

List of Figures

Figure 1. Neuromodulation Devices and Implantable Infusion Pumps Picture

Figure 2. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type in 2021

Figure 3. Spinal Cord Stimulation

Figure 4. Deep Brain Stimulation

Figure 5. Sacral Nerve Stimulation

Figure 6. Vagal Nerve Stimulation

Figure 7. Gastric Stimulation

Figure 8. Transcranial Magnetic Stimulation

Figure 9. Transcutaneous Electrical Stimulation

Figure 10. Other

Figure 11. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application in 2021

Figure 12. Parkinson's Disease

Figure 13. Epilepsy

Figure 14. Pain

Figure 15. Other

Figure 16. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue, (USD Million) & (Unit): 2017 & 2021 & 2028

Figure 17. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Forecast (2017-2028) & (USD Million)

Figure 18. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (2017-2028) & (Unit)

Figure 19. Global Neuromodulation Devices and Implantable Infusion Pumps Price (2017-2028) & (USD/Unit)

Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Production Capacity (2017-2028) & (Unit)

Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Production Capacity by Geographic Region: 2022 VS 2028

Figure 22. Neuromodulation Devices and Implantable Infusion Pumps Market Drivers

Figure 23. Neuromodulation Devices and Implantable Infusion Pumps Market Restraints

Figure 24. Neuromodulation Devices and Implantable Infusion Pumps Market Trends

Figure 25. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturer in 2021

Figure 26. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Manufacturer in 2021

Figure 27. Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 28. Top 3 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer (Revenue) Market Share in 2021

Figure 29. Top 6 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer (Revenue) Market Share in 2021

Figure 30. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2017-2028)

Figure 31. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2017-2028)

Figure 32. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue (2017-2028) & (USD Million)

Figure 33. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue (2017-2028) & (USD Million)

Figure 34. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue (2017-2028) & (USD Million)

Figure 35. South America Neuromodulation Devices and Implantable Infusion Pumps Revenue (2017-2028) & (USD Million)

Figure 36. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue (2017-2028) & (USD Million)

Figure 37. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2017-2028)

Figure 38. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2017-2028)

Figure 39. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2017-2028) & (USD/Unit)

Figure 40. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2017-2028)

Figure 41. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2017-2028)

Figure 42. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2017-2028) & (USD/Unit)

Figure 43. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2017-2028)

Figure 44. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2017-2028)

Figure 45. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2017-2028)

Figure 46. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2017-2028)

Figure 47. United States Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Canada Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Mexico Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2017-2028)

Figure 51. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2017-2028)

Figure 52. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2017-2028)

Figure 53. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2017-2028)

Figure 54. Germany Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. France Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. United Kingdom Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Russia Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Italy Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2017-2028)

Figure 60. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2017-2028)

Figure 61. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2017-2028)

Figure 62. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2017-2028)

Figure 63. China Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Korea Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. India Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Australia Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2017-2028)

Figure 70. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2017-2028)

Figure 71. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2017-2028)

Figure 72. South America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2017-2028)

Figure 73. Brazil Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Argentina Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2017-2028)

Figure 76. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2017-2028)

Figure 77. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2017-2028)

Figure 78. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2017-2028)

Figure 79. Turkey Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Egypt Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. South Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps in 2021

Figure 84. Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps

Figure 85. Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain

Figure 86. Sales Channel: Direct Channel vs Indirect Channel

Figure 87. Methodology

Figure 88. Research Process and Data Source